Of note, active caspase 3/7 staining of ceritinib-treated tumor cells showed a significant increase of apoptotic cells, suggesting that nuclear membrane disruption and mitochondrial relocalization contributes to programmed cell death (Fig. 4I). This evidence concerns the gene CASP3 and neoplasm.